Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELS-M11 in Acute Migraine
NCT02057315Phase 2Completed
- Sponsor
- Achelios Therapeutics
- Start
- Mar 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketoprofen in migraine (2 arms), sponsored by Achelios Therapeutics. Primary endpoint: Percentage of patients who experience pain relief 2 hours following the first application of ELS-M11. Started Mar 2014; status: completed.
02
Drugs
ketoprofen
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02057315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02057315.